CONTEMPORARY DATA ABOUT ETIOLOGY AND PATHOGENESIS OF NOSOCOMIAL PNEUMONIA. MODERN APPROACHES OF ANTIBIOTIC THERAPY
Abstract
Etiology and pathogenesis of nosocomial pneumo-nia are observed. New principles of starting empirical antibiotic therapy are presented. Advantages of meropenem starting phar-macotherapy of nosocomial pneumonia are discussed and sub-stantiated in our article.
About the Authors
E. V. Eliseeva
Vladivostok State Medical University
Russian Federation
Russian Federation
O. S. Petrova
Vladivostok State Medical University
Russian Federation
Russian Federation
D. N. Kirillin
Vladivostok State Medical University
Russian Federation
Russian Federation
E. F. Romanchenko
Vladivostok State Medical University
Russian Federation
Russian Federation
References
1. Гельфанд Б.Р., Гологорский В.А., Белоцерковский Б.З.// Нозокомиальная пневмония, связанная с искусственной вентиляцией легких у хирургических больных. — М. :2000.
2. Ноников В.Е. // В мире лекарств. — 1998. — № 1. — С. 8-17.
3. Ноников В.Е. // Русский медицинский журнал. — 1997. - Т. 5, № 24. - С. 1568-1578.
4. Рациональная антимикробная фармакотерапия / Под ред. В.П. Яковлева, С.В. Яковлева. — М. : Литтера, 2003.
5. Сидоренко С.В., Резван С.П., Грудинина С.А. и др. //Антибиотики и химиотерапия. — 1998. — № 1. — С. 4-14.
6. Яковлев С.В., Яковлев В.П., Деревянко И.И. и др. //Антибиотики и химиотерапия. — 1998. — № 1. — С. 15-24.
7. Яковлев С.В. // Пульмонология. — 1997. — Прил. — С. 49-57.
8. Aoun М., Klastersky J. //Drugs. - 1991. - Vol. 42. - P. 962-973.
9. Bowton D.L. // Amer. Col. Chest Phys. - 1999. - Vol. 115. - P. 28-33.
10. Brown E. //J. Antimicrobial Chemotherapy. — 1997. — Vol. 40, No. 4. - P. 463-468.
11. Celis R., Torres A., Gatell J. et al. //Ibid. - 1998. - Vol. 93. - P. 318-324.
12. Fagon J.A., Chastre J., Vuagnot A. et al. // J. Am. Med. Assoc. - 1996. - Vol. 275, No. 11. - P. 866-869.
13. Finch R., Pemberton К., Gildon К. // J. Chemotherapy. - 1998. - Vol. 10, No. 1. - P. 35-46.
14. Finch R., Woodhead M. //Drugs. - 1998. - Vol. 55, No. 1. - P. 31-45.
15. Fink M.P., Snydman D.R., Niederman M.S. et al. //Antimicrob. Agents Chemother. - 1994. - Vol. 83. - P. 547-557.
16. Graven D., Steger K.//Ibid. - 1995.- Vol. 108, No. 2. - P. 1S-16S.
17. Graven D., Steger K. //Semin. Respir. Infect. — 1996. — Vol. 11, No. 1. - P. 32-53.
18. Ibrahim et al. //Crit. Care Med. - 2001. - Vol. 29. - P. 1109-1115.
19. Iregui et al. //Chest. - 2002. - Vol. 122. - P. 262-268.
20. Janknegt R., van der Meer JWM//J. Antimicrob. Chemother. - 1994. - Vol. 33. - P. 169-177.
21. Kollef M.H., Silver P.//Respir. Care. - 2003. - Vol. 40, No. 11. - P. 1130-1140.
22. Meropenem — efficacy in the management of critically ill patients. — Zeneca Pharmaceuticals. — Data on file.
23. PatzerJ., Dzierzanowska D. //ECCMID, 2002. - P. 789.
24. Sieger В., Berman S., Geckler R., Farkas S. // Critical Care Medicine. - 1997. - Vol. 25, No. 10. - P. 1663-1670.
25. Young L. // Clinical Microbiology and Infection. — 1997. - Vol. 3, Suppl. 4. - P. 4S60-4S65.
Review
For citations:
Eliseeva E.V., Petrova O.S., Kirillin D.N., Romanchenko E.F. CONTEMPORARY DATA ABOUT ETIOLOGY AND PATHOGENESIS OF NOSOCOMIAL PNEUMONIA. MODERN APPROACHES OF ANTIBIOTIC THERAPY. Pacific Medical Journal. 2005;(1):9-12. (In Russ.)
Views:
265
Email this article 